The following is a summary of “Examining the Effect of Intramuscular vs Intravenous Metoclopramide for Treatment of Acute ...

Diabetes mellitus is a risk factor for the development of gastroparesis. Currently, metoclopramide is the only US FDA-approved medication for the treatment of gastroparesis. However, the FDA ...

Metoclopramide stimulates motility of the upper gastrointestinal tract without stimulating gastric, biliary, or pancreatic secretions. The exact mechanism of action of metoclopramide in the ...

Metoclopramide use during early pregnancy was not associated with excess risk for congenital malformations. In the U.S., treatment of nausea and vomiting during early pregnancy usually involves ...